share_log

シンバイオ製薬:末梢性T細胞リンパ腫(PTCL)に対するブリンシドフォビルの抗腫瘍効果を確認 がん原遺伝子MYCの抑制及び免疫調整遺伝子の発現を誘導

SymBio Pharmaceuticals: Confirmed antitumor effect of brentuximab vedotin on peripheral T-cell lymphoma (PTCL), inducing suppression of oncogene MYC and expression of immune regulatory genes.

JPX ·  Jun 23 19:45
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more